Treatment-resistant depression (TRD) is a particularly challenging form of major depressive disorder. As Albino Oliveira-Maia, head of the Champalimaud Foundation's Neuropsychiatry Unit and the study's national coordinator ...
Oct 4, 2023
0
77
Loss of the "housekeeping" gene methylthioadenosine phosphorylase, or MTAP, is a common event in cancer. Patients with melanoma or bladder cancer whose tumor cells lack a functioning version of the gene tend not to respond ...
Sep 28, 2023
0
0
For patients with major depressive disorder, an electroencephalography (EEG)-based model can predict response to selective serotonin reuptake inhibitor (SSRI) medications, according to a study published online Sept. 28 in ...
Sep 28, 2023
0
1
Researchers at Baylor College of Medicine have developed a new compound called d16 that can reduce tumor growth and overcome therapeutic resistance in mutant p53-bearing cancers in the lab. The findings, published in the ...
Sep 27, 2023
0
9
A team led by scientists from the Trinity Biomedical Sciences Institute (TBSI) has unearthed the possible target for treating the debilitating skin disease hidradenitis suppurativa (HS), which is a painful, chronic, inflammatory ...
Sep 26, 2023
0
0
Baby blues occurs in most new mothers, but 1 in 6 will go on to develop the more crushing symptoms of postpartum depression, which in severe and rare cases can lead to psychosis, and, in offspring, insecure attachment, difficulty ...
Sep 26, 2023
0
0
For certain patients with advanced breast cancer, a drug called Piqray (alpelisib) may extend survival. But new research confirms the medication often causes seriously high blood sugar levels.
Sep 25, 2023
0
8
University of Queensland researchers have identified a novel drug target with the potential to overcome drug resistance and prevent tumor regrowth in cancer patients.
Sep 21, 2023
0
1
A new editorial paper titled "Potential repurposing of DPP4 inhibitors for target therapy resistance in renal cell carcinoma" has been published in Oncotarget.
Sep 20, 2023
0
1
A team of Dana-Farber researchers has identified a potential new way to assess clinically valuable features of clear cell renal cell carcinoma (ccRCC), a form of kidney cancer, using image processing with deep learning. Their ...
Sep 19, 2023
0
57
